SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-23-000110
Filing Date
2023-05-04
Accepted
2023-05-04 07:44:21
Documents
1
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168320064396131.html 4  
1 FORM 4 wf-form4_168320064396131.xml 4 19001
  Complete submission text file 0001640455-23-000110.txt   20375
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O JOUNCE THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE BOSTON MA 02210
Business Address
Kamen Robert (Reporting) CIK: 0001693540 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 23886555